Antagonist of prostaglandin E2 receptor 4 induces metabolic alterations in liver of mice

Journal of Proteome Research

Volumn 14, Issue 3, 2015, Pages 1566-1573

  Li, Ning ^a   Zhang, Limin ^a   An, Yanpeng ^b   Zhang, Lulu ^a   Song, Yipeng ^a   Wang, Yulan ^a,c   Tang, Huiru ^a,b  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b FUDAN UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

L 161982; metabonomics; NMR; prostaglandin E2 receptor 4; transcriptomics

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ASPARTIC ACID; CHOLESTEROL; CHOLINE; GLUTAMINE; GLUTATHIONE DISULFIDE; GLYCOGEN; HYPOXANTHINE; LACTIC ACID; LIVER EXTRACT; LYSINE; MONOUNSATURATED FATTY ACID; PHENYLALANINE; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E RECEPTOR 4 ANTAGONIST; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; SATURATED FATTY ACID; SUCCINIC ACID; TYROSINE; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID; URACIL; URIDINE PHOSPHATE; XANTHINE; L-161982; THIOPHENE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; FATTY ACID METABOLISM; LIPID COMPOSITION; LIVER METABOLISM; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; NUCLEOTIDE METABOLISM; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSCRIPTOMICS; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; DRUG EFFECTS; LIVER; METABOLISM;

MUS;

ANIMALS; LIVER; MALE; MICE; MICE, INBRED BALB C; PROTON MAGNETIC RESONANCE SPECTROSCOPY; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; THIOPHENES; TRIAZOLES;

EID: 84924356997     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr501236y     Document Type: Article

References (60)

1. Smith, W. L.; DeWitt, D. L.; Garavito, R. M. Cyclooxygenases: Structural, cellular, and molecular biology Annu. Rev. Biochem. 2000, 69, 145-82
2. Coleman, R. A.; Smith, W. L.; Narumiya, S. International union of pharmacology classfication of prostanoid receptors-properties, distribution, and structure of the receptors and their subtypes Pharmacol. Rev. 1994, 46 (2) 205-229
3. An, S. Z.; Yang, J. H.; Xia, M. H. Cloning and expression of the EP2 subtype of human receptors for prostaglandin-E2 Biochem. Biophys. Res. Commun.. 1993, 197 (1) 263-270
4. Yokoyama, U.; Iwatsubo, K.; Umemura, M. The prostanoid EP4 receptor and its signaling pathway Pharmacol. Rev. 2013, 65 (3) 1010-1052
5. Konya, V.; Marsche, G.; Schuligoi, R. E-type prostanoid receptor 4 (EP4) in disease and therapy Pharmacol. Ther. 2013, 138 (3) 485-502
6. Kundu, N.; Ma, X.; Kochel, T. Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties Breast Cancer Res. Treat. 2014, 143 (1) 19-31
7. Xu, S.; Zhang, Z. Y.; Ogawa, O. An EP4 antagonist ONO-AE3-208 suppresses cell invasion, migration, and metastasis of prostate cancer Cell Biochem. Biophys. 2014, 70 (1) 521-527
8. Qian, J. Y.; Harding, P.; Liu, Y. H. Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction Hypertension 2008, 51 (2) 560-566
9. Walch, L.; Labat, C.; Gascard, J. P. Prostanoid receptors involved in the relaxation of human pulmonary vessels Br. J. Pharmacol. 1999, 126 (4) 859-866
10. McCoy, J. M.; Wicks, J. R.; Audoly, L. P. The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis J. Clin. Invest. 2002, 110 (5) 651-658
11. Araki, H.; Ukawa, H.; Sugawa, Y. The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach Aliment. Pharmacol. Ther. 2000, 14, 116-124
12. Takeuchi, K.; Yagi, K.; Kato, S. Roles of prostaglandin E-receptor subtypes in gastric and duodenal bicarbonate secretion in rats Gastroenterology 1997, 113 (5) 1553-1559
13. Leduc, M.; Hou, X.; Hamel, D. Restoration of renal function by a novel prostaglandin EP4 receptor-derived peptide in models of acute renal failure Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013, 304 (1) R10-R22
14. Yao, C.; Sakata, D.; Esaki, Y. Prostaglandin E2-EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion Nat. Med. 2009, 15 (6) 633-640
15. Soontrapa, K.; Honda, T.; Sakata, D. Prostaglandin E2-prostoglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation-induced systemic immunosuppression Proc. Natl. Acad. Sci. U. S. A. 2011, 108 (16) 6668-6673
16. Hoggatt, J.; Mohammad, K. S.; Singh, P. Differential stem- and progenitor-cell trafficking by prostaglandin E2 Nature 2013, 495 (7441) 365-369
17. Segi, E.; Sugimoto, Y.; Yamasaki, A. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice Biochem. Biophys. Res. Commun.. 1998, 246 (1) 7-12
18. Yokoyama, U.; Minamisawa, S.; Quan, H. Chronic activation of the prostaglandin recepor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus J. Clin. Invest. 2006, 116 (11) 3026-3034
19. Xiao, C. Y.; Yuhki, K.; Hara, A. Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4 Circulation 2004, 109 (20) 2462-2468
20. Stachura, J.; Tarnawski, A.; Ivey, K. J. Prostaglandin protection of carbon tetrachloride-induced liver cell necrosis in the rat Gastroenterology 1981, 81 (2) 211-7
21. Takano, M.; Nishimura, H.; Kimura, Y. Prostaglandin E-2 protects against liver injury after Escherichia coli infection but hampers the resolution of the infection in mice J. Immunol. 1998, 161 (6) 3019-3025
22. Kuzumoto, Y.; Sho, M.; Ikeda, N. Significance and therapeutic potential of prostaglandin E2 receptor in hepatic ischemia/reperfusion injury in mice Hepatology 2005, 42 (3) 608-617
23. Takahashi, S.; Takeuchi, K.; Okabe, S. EP4 receptor mediation of prostaglandin E2-stimulated mucus secretion by rabbit gastric epithelial cells Biochem. Pharmacol. 1999, 58 (12) 1997-2002
24. Machwate, M.; Harada, S.; Leu, C. T. Prostaglandin receptor EP4 mediates the bone anabolic effects of PGE(2) Mol. Pharmacol. 2001, 60 (1) 36-41
25. Cherukuri, D. P.; Chen, X. B. O.; Goulet, A. C. The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells Exp. Cell. Res. 2007, 313 (14) 2969-2979
26. An, Y. P.; Xu, W. X.; Li, H. H. High-fat diet induces dynamic metabolic alterations in multiple biological matrices of rats J. Proteome Res. 2013, 12 (8) 3755-3768
27. Duan, Y. X.; An, Y. P.; Li, N. Multiple univariate data analysis reveals the inulin effects on the high-fat-diet induced metabolic alterations in rat myocardium and testicles in the preobesity state J. Proteome Res. 2013, 12 (7) 3480-3495
28. Xu, W. X.; Wu, J. F.; An, Y. P. Streptozotocin-induced dynamic metabonomic changes in rat biofluids J. Proteome Res. 2012, 11 (6) 3423-3435
29. Zhang, X. Y.; Wang, Y. L.; Hao, F. H. Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statuses J. Proteome Res. 2009, 8 (11) 5188-5195
30. 1H nuclear magnetic resonance spectroscopy and principal component analysis Prog. Biochem. Biophys. 2008, 35 (10) 1142-1153
31. 1H NMR spectroscopy in conjunction with multivariate data analysis J. Proteome Res. 2007, 6 (7) 2605-2614
32. 1H NMR spectroscopy J. Proteome Res. 2013, 12 (6) 2958-2966
33. Dong, F. C.; Wang, B.; Zhang, L. L., Metabolic response to Klebsiella pneumoniae infection in an experimental rat model. PLoS One 2012, 7, (11).
34. Li, H. H.; An, Y. P.; Zhang, L. L. Combined NMR and GC-MS analyses revealed dynamic metabolic changes associated with the carrageenan-induced rat pleurisy J. Proteome Res. 2013, 12 (12) 5520-5534
35. Zhu, X.; Lei, H.; Wu, J. Systemic responses of BALB/c mice to salmonella typhimurium infection J. Proteome Res. 2014, 13 (10) 4436-4445
36. 4-Induced systems alterations for multiple rat organs J. Proteome Res. 2012, 11 (7) 3848-3859
37. Zhang, L.; Ye, Y.; An, Y. Systems responses of rats to aflatoxin B1 exposure revealed with metabonomic changes in multiple biological matrices J. Proteome Res. 2011, 10 (2) 614-623
38. Huang, C. Y.; Lei, H. H.; Zhao, X. J. Metabolic influence of acute cyadox exposure on Kunming mice J. Proteome Res. 2013, 12 (1) 537-545
39. Shi, X. H.; Xiao, C. N.; Wang, Y. L. Gallic acid intake induces alterations to systems metabolism in rats J. Proteome Res. 2013, 12 (2) 991-1006
40. Li, H.; Wei, H.; Wang, Y. Enhanced green fluorescent protein transgenic expression in vivo is not biologically inert J. Proteome Res. 2013, 12 (8) 3801-3808
41. Xiao, C. N.; Hao, F. H.; Qin, X. R. An optimized buffer system for NMR-based urinary metabonomics with effective pH control, chemical shift consistency and dilution minimization Analyst 2009, 134 (5) 916-925
42. Ding, L. N.; Hao, F. H.; Shi, Z. M. Systems biological responses to chronic perfluorododecanoic acid exposure by integrated metabonomic and transcriptomic studies J. Proteome Res. 2009, 8 (6) 2882-2891
43. Eriksson, L.; Trygg, J.; Wold, S. CV-ANOVA for significance testing of PLS and OPLS (R) models J. Chemom. 2008, 22 (11-12) 594-600
44. 1H NMR spectroscopic metabonomic studies Anal. Chem. 2005, 77 (2) 517-526
45. Xu, Z. D.; Harvey, K.; Pavlina, T. An improved method for determining medium- and long-chain FAMEs using gas chromatography Lipids 2010, 45 (2) 199-208
46. 13C NMR spectroscopy of human blood plasma Anal. Chem. 1995, 67 (5) 793-811
47. Fan, T. W. M. Metabolite profiling by one-and two-dimensional NMR analysis of complex mixtures Magn. Reson. Chem. 1996, 28 (2) 161-219
48. Boes, E.; Kollerits, B.; Heid, I. M. INSIG2 polymorphism is neither associated with BMI nor with phenotypes of lipoprotein metabolism Obesity 2008, 16 (4) 827-833
49. Han, J. H.; Hajjar, D. P.; Febbraio, M. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36 J. Biol. Chem. 1997, 272 (34) 21654-21659
50. Ikeda, H.; Ueda, M.; Ikeda, M. Oxysterol 7 alpha-hydroxylase (CYP39A1) in the ciliary nonpigmented epithelium of bovine eye Lab. Invest. 2003, 83 (3) 349-355
51. Riancho, J. A.; Vázquez, L.; García-Pérez, M. A. Association of ACACB polymorphisms with obesity and diabetes Mol. Genet. Metab. 2011, 104 (4) 670-676
52. McGarry, J. D.; Brown, N. F. The mitochondrial carnitine palmitoyltransferase system-from concept to molecular analysis Eur. J. Biochem. 1997, 244 (1) 1-14
53. Pashkov, V.; Huang, J.; Parameswara, V. K. Regulator of G protein signaling (RGS16) inhibits hepatic fatty acid oxidation in a carbohydrate response element-binding protein (ChREBP)-dependent manner J. Biol. Chem. 2011, 286 (17) 15116-15125
54. Anderson, M. E. Glutathione: An overview of biosynthesis and modulation Chem. Biol. Interact. 1998, 112, 1-14
55. Cho, S.-G.; Lee, Y. H.; Park, H.-S. Glutathione s-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1 J. Biol. Chem. 2001, 276 (16) 12749-12755
56. Weinhold, P. A.; Rethy, V. B. Separation, purification, and characterization of ethanolamine kinase and choline kinase from rat liver Biochemistry 1974, 13 (25) 5135-5141
57. Cappiello, M.; Mascia, L.; Scolozzi, C. In vitro assessment of salvage pathways for pyrimidine bases in rat liver and brain Biochim. Biophys. Acta 1998, 1425 (2) 273-281
58. Eckel-Mahan, K. L.; Patel, V. R.; Mohney, R. P. Coordination of the transcriptome and metabolome by the circadian clock Proc. Natl. Acad. Sci. U. S. A. 2012, 109 (14) 5541-5546
59. Bjursell, M. K.; Blom, H. J.; Cayuela, J. A. Adenosine kinase deficiency disrupts the methionine cycle and causes hypermethioninemia, encephalopathy, and abnormal liver function Am. J. Hum. Genet. 2011, 89 (4) 507-515
60. Kizaki, H.; Williams, J. C.; Morris, H. P. Increased cytidine 5′-triphosphate synthetase activity in rat and human tumors Cancer Res. 1980, 40 (11) 3921-3927